# A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease

> **NCT06544694** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 80 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** 0.003% AR-15512 ophthalmic solution
- **OTHER:** Artificial Tears

## Key facts

- **NCT ID:** NCT06544694
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-08
- **Primary completion:** 2025-03-21
- **Final completion:** 2025-03-21
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06544694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06544694, "A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06544694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*